author-photo

Heike Hofmann-Winkler

German Primate Center

28

Papers

1817

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (56)
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization

2021 Cell Reports
Show All
- Source
- Cite
- Save
Citations (21)
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.

2021 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (86)
Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.

2021 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (13)
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (57)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

2021 Cell
Show All
- Source
- Cite
- Save
Citations (340)
Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.

2021
Show All
- Source
- Cite
- Save
Citations (5)
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (3)
Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study

2021 Frontiers of Medicine in China
Show All
- Source
- Cite
- Save
Citations (5)
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.

2021 Cell Reports
Show All
- Source
- Cite
- Save
Citations (53)